3.
n | % | |
No. of chemotherapy regimens before gefitinib | ||
0 | 2 | 11.1% |
1 | 11 | 61.1% |
2 | 5 | 27.8% |
Best response to gefitinib | ||
PR | 12 | 66.7% |
SD | 6 | 33.3% |
Interval from discontinuation of gefitinib to 2nd EGFR-TKIs | ||
Median (95%CI) (month) | 5.86 (5.42-12.36) | |
PFS-1stTKI | ||
Median (95%CI) (month) | 12.22 (10.93-18.81) | |
PFS-2ndTKI | ||
Median (95%CI) (month) | 5.16 (4.44-11.27) |